Serum free light chain difference and beta-2 microglobulin levels are risk factors for thromboembolic events in patients with AL amyloidosis

Conclusion The incidence of thromboembolism was substantial in AL amyloidosis. Higher FLC difference and B2MG levels were risk factors for thromboembolic events. Teaser AL amyloidosis may increase the risk for thromboembolism as well as other plasma cell dyscrasias. Therefore, we evaluated the features of thromboembolism in AL amyloidosis. The incidence of thromboembolism was substantial (12.3%); most events developed within the first year after diagnosis and arterial thromboembolism occurred frequently. Especially, patients with risk factors may require close monitoring for thromboembolism.
Source: Clinical Lymphoma Myeloma and Leukemia - Category: Cancer & Oncology Source Type: research